Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,160
Recruiting: 666
Ph III recruiting: 61
Growth YoY: +9.3%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (561)

clinicaltrialsPublishedShowing 451–500 of 923 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04077372	Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers	terminated	N/A	12	Stanford UniversityOTHER	1	Jan 27, 2023	clinicaltrials
NCT02654028	Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection(AT/HCC)	completed	N/A	618	Guangxi Medical UniversityOTHER	1	Jan 25, 2023	clinicaltrials